A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.

BACKGROUND There remains no FDA approved medication for the treatment of cocaine dependence. Preclinical studies and early pilot clinical investigations have suggested that N-acetylcysteine (NAC) may be useful in the treatment of the disorder. OBJECTIVE The present report assessed the efficacy of NAC in the treatment of cocaine dependence. METHODS Cocaine-dependent volunteers (n = 111) were randomized to receive daily doses of 1,200 mg of NAC, 2,400 mg of NAC, or placebo. Participants were followed for 8 weeks (up to three visits weekly). At each of these visits, urine samples were collected, along with self-reports of cocaine use. Urine samples were assessed for quantitative levels of benzoylecognine (ie, cocaine metabolite). RESULTS Overall, the primary results for the clinical trial were negative. However, when considering only subjects who entered the trial having already achieved abstinence, results favored the 2,400 mg NAC group relative to placebo, with the 2,400 mg group having longer times to relapse and lower craving ratings. CONCLUSION While the present trial failed to demonstrate that NAC reduces cocaine use in cocaine-dependent individuals actively using, there was some evidence it prevented return to cocaine use in individuals who had already achieved abstinence from cocaine. SCIENTIFIC SIGNIFICANCE N-acetylcysteine may be useful as a relapse prevention agent in abstinent cocaine-dependent individuals.

[1]  P. Kalivas,et al.  The Effect of N-Acetylcysteine in the Nucleus Accumbens on Neurotransmission and Relapse to Cocaine , 2012, Biological Psychiatry.

[2]  R. Risinger,et al.  Repeated N-Acetyl Cysteine Reduces Cocaine Seeking in Rodents and Craving in Cocaine-Dependent Humans , 2011, Neuropsychopharmacology.

[3]  A. Alterman,et al.  Reliability and validity of the Cocaine Selective Severity Assessment. , 1998, Addictive behaviors.

[4]  J. Seamans,et al.  Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking , 2005, The Journal of Neuroscience.

[5]  P. Kalivas,et al.  The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans , 2009, Biological Psychiatry.

[6]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[7]  K. Gray,et al.  N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. , 2010, The American journal on addictions.

[8]  P. Kalivas,et al.  Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse , 2003, Nature Neuroscience.

[9]  K. Lynch,et al.  A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence , 2005, Neuropsychopharmacology.

[10]  Walter Ling,et al.  Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. , 2003, The Journal of clinical psychiatry.

[11]  P. Kalivas,et al.  Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2003, The Journal of Neuroscience.

[12]  K. Brady,et al.  A controlled trial of amlodipine for cocaine dependence: a negative report. , 2005, Journal of substance abuse treatment.

[13]  Suck-Won Kim,et al.  N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. , 2009, Archives of general psychiatry.

[14]  P. Kalivas,et al.  The Role of N-Acetylcysteine in Inhibiting Responding During Extinction in Rats Trained to Self-Administer Cocaine. , 2010, The open addiction journal.

[15]  Peter W. Kalivas,et al.  An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  P. Kalivas,et al.  Is cocaine desire reduced by N-acetylcysteine? , 2007, The American journal of psychiatry.

[17]  P. Kalivas,et al.  Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse , 2010, Proceedings of the National Academy of Sciences.

[18]  M. Foster Olive,et al.  N-Acetylcysteine Reverses Cocaine Induced Metaplasticity , 2009, Nature Neuroscience.

[19]  K. Preston,et al.  Assessment of cocaine use with quantitative urinalysis and estimation of new uses. , 1997, Addiction.

[20]  L. Sobell,et al.  Validity of self-reports in three populations of alcoholics. , 1978, Journal of consulting and clinical psychology.

[21]  M. Hearing,et al.  Repeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine , 2007, The Journal of Neuroscience.

[22]  F. Weiss,et al.  Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer , 2004, The Journal of Neuroscience.

[23]  P. Kalivas,et al.  Chronic N-Acetylcysteine during Abstinence or Extinction after Cocaine Self-Administration Produces Enduring Reductions in Drug Seeking , 2011, Journal of Pharmacology and Experimental Therapeutics.

[24]  L. Honos-Webb,et al.  The Measurement of Craving , 2001, Journal of addictive diseases.

[25]  J. Peters,et al.  The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats , 2006, Psychopharmacology.

[26]  K. Brady,et al.  A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. , 2012, The American journal of psychiatry.

[27]  Hugh Myrick,et al.  Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. , 2006, The American journal on addictions.